BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34331411)

  • 1. Sarcomatoid hepatocellular carcinoma: From clinical features to cancer genome.
    Zhang C; Feng S; Tu Z; Sun J; Rui T; Zhang X; Huang H; Ling Q; Zheng S
    Cancer Med; 2021 Sep; 10(18):6227-6238. PubMed ID: 34331411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma.
    Hashiba T; Yamashita T; Okada H; Nio K; Hayashi T; Asahina Y; Hayashi T; Terashima T; Iida N; Takatori H; Shimakami T; Kawaguchi K; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Takamura H; Ohta T; Honda M; Kaneko S
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):269-285. PubMed ID: 32169577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance and function of
    Chen YR; Li YT; Wang MQ; Zhu SL
    Future Oncol; 2021 Nov; 17(33):4457-4470. PubMed ID: 34350781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
    Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma.
    Wang JP; Yao ZG; Sun YW; Liu XH; Sun FK; Lin CH; Ren FX; Lv BB; Zhang SJ; Wang Y; Meng FY; Zheng SZ; Gong W; Liu J
    World J Gastroenterol; 2020 Aug; 26(29):4327-4342. PubMed ID: 32848337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma.
    Maimaitiming A; Zhou X; Ma X; Huang Y; Wang Q; Deng R; Ren Y; Chai X; Zhang P
    J Invest Surg; 2020 Jul; 33(6):536-541. PubMed ID: 30543135
    [No Abstract]   [Full Text] [Related]  

  • 10. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis.
    Wu L; Tsilimigras DI; Farooq A; Hyer JM; Merath K; Paredes AZ; Mehta R; Sahara K; Shen F; Pawlik TM
    Cancer; 2019 Nov; 125(21):3767-3775. PubMed ID: 31299092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
    Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN
    Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomatoid hepatocellular carcinoma (SHC): a case report.
    Yu Y; Zhong Y; Wang J; Wu D
    World J Surg Oncol; 2017 Dec; 15(1):219. PubMed ID: 29233162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.
    Victor DW; Monsour HP; Boktour M; Lunsford K; Balogh J; Graviss EA; Nguyen DT; McFadden R; Divatia MK; Heyne K; Ankoma-Sey V; Egwim C; Galati J; Duchini A; Saharia A; Mobley C; Gaber AO; Ghobrial RM
    Transplantation; 2020 Jan; 104(1):113-121. PubMed ID: 31233480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
    Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
    Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
    Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of gene therapy on postoperative recurrence of small hepatocellular carcinoma (less than 5cm).
    Meng J; Zhang JG; Du ST; Li N
    Cancer Gene Ther; 2019 Mar; 26(3-4):114-117. PubMed ID: 30190512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmentalized evolution of hepatitis B virus contributes differently to the prognosis of hepatocellular carcinoma.
    Yin J; Chen X; Li N; Han X; Liu W; Pu R; Wu T; Ding Y; Zhang H; Zhao J; Han X; Wang H; Cheng S; Cao G
    Carcinogenesis; 2021 Apr; 42(3):461-470. PubMed ID: 33247709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.